Pittsfield Announces COVID-19 Small Business Recovery Funding

Print Story | Email Story
PITTSFIELD, Mass. — The City of Pittsfield is now accepting applications for the second round of COVID-19 Small Business Recovery grant funds.
 
The small business fund is part of the City of Pittsfield's COVID-19 Economic Recovery Program established by Mayor Linda Tyer in April 2020. This round of small business grants are funded by the Department of Housing and Urban Development and the Community Development Block Grant (CDBG) program.
 
The purpose of the grant is to provide funding to low or moderate income business owners who have had significant business disruption due to the impact of COVID-19. Additionally, this funding is intended to help businesses remain open (if able under state guidelines) and also help them to pivot, as needed. Grants of up to $10,000 will be awarded to eligible businesses.
 
"We will be giving special consideration to microenterprises, Black, Indigenous people of color, women, veterans, and those in the LGBTQIA business community," said Community Development Specialist Laura Mick.
 
In the first round of funding, the City of Pittsfield awarded a total of $682,000 to 90 small businesses in the city. Businesses which received funding include those from the following industries: hospitality, restaurants, spas and salons, recreational and fitness, builders, markets, and retail, as well as, entertainment.
 

Tags: COVID-19,   


More Coronavirus Updates

Keep up to date on the latest COVID-19 news:


If you would like to contribute information on this article, contact us at info@iberkshires.com.

Kratom Products Pulled From Pittsfield, Statewide Shelves

By Brittany PolitoiBerkshires.com Staff

PITTSFIELD, Mass.— The state has put an emergency yearlong order on kratom products, and Pittsfield is working with retailers to remove the product from shelves. 

Last week, Director of Public Health Andy Cambi delivered an update on the emergency order that went into effect on August 28.  Also known by its chemical name and marketed with the term "7-OH," Massachusetts temporarily designated kratom as a Schedule I drug, greatly restricting sales. 

The formerly unregulated product has resulted in emergency room visits, poison control calls, and deaths.  

"Dependency and the opioid-like withdrawal symptoms are the major key health concerns," Cambi explained. "Liver toxicity, seizures, just a greater overdose risk when combined with other substances, and then the main thing is that this is not regulated."

He said that throughout the years, retail shops have reached out to the Health Department looking for guidance on kratom products and were notified that it is unregulated. 

"And for the most part, when they hear that, they don't sell the product," he added. 

Kratom is a leafy plant native to Southeast Asia containing naturally occurring substances, including mitragynine and 7-hydroxymitragynine (7-OH).  It is marketed to relieve pain and can produce stimulating or sedating effects, depending on the amount taken and potency. Newer products contain highly concentrated or laboratory-modified compounds that can have significantly stronger opioid-like effects. 

Kratom products have been widely sold in smoke shops, convenience stores, and gas stations as powders, tablets, capsules, gummies, dissolvable strips, and in other forms.

View Full Story

More Pittsfield Stories